pancreatic cancer semaglutide Can Cause Cancer? Know the Potential GLP-1 Risks GLP-1s appear to cut cancer

[1] Tirzepatide (Mounjaro, Zepbound) drives at least as much weight loss and the same slowed digestion, so although the studies below are drawn from semaglutide, the same routes apply to it

Theyre not really rivals, they just work in different lanes

And you'll never forget that

Semaglutide Sodium (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), ein langwirksames Glucagon-hnliches Peptid 1 (GLP-1)-Analogon, ist ein GLP-1-Rezeptor -Agonist mit Potenzial fr die Behandlung von Typ-2-Diabetes mellitus (T2DM)

At clinical doses, the peptide activates collagen synthesis, accelerates cell turnover, and modulates the inflammatory response across multiple tissue types

119 SimonsK.GerlM